Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
140
Total 13F shares, excl. options
36M
Shares change
+6.53M
Total reported value, excl. options
$2.61B
Value change
+$445M
Put/Call ratio
0.91
Number of buys
95
Number of sells
-57
Price
$72.49

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2021

173 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q3 2021.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36M shares of 264M outstanding shares and own 13.63% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (7.18M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.88M shares), Cederberg Capital Ltd (2.32M shares), BlackRock Inc. (1.89M shares), Zeal Asset Management Ltd (1.7M shares), MORGAN STANLEY (1.43M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.2M shares), VANGUARD GROUP INC (951K shares), PICTET ASSET MANAGEMENT SA (931K shares), and PRINCIPAL FINANCIAL GROUP INC (849K shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.